RX 360 JOINT AUDIT PROGRAM

Welcome to the Brand page for “RX 360 JOINT AUDIT PROGRAM”, which is offered here for The mark consists of a capital r with the downward part of the angled leg of the r forming one half of a lower case x to the right and lower than the r next to the numbers 360 with the angled leg circling numbers 360 and a stylized global with an arching curved line reaching from the right of the r to the inside of the angled leg, with all the foregoing centered over the words joint audit program with initial capital letters and the letters forming the words joint audit being thicker than the word program.;rx three sixty joint audit program;color is not claimed as a feature of the mark.;rx or audit program;organizing and conducting a product safety auditing program of pharmaceutical suppliers and pharmaceutical ingredient suppliers for technical analysis and evaluation of potential risks and safeguards; organizing and conducting an audit sharing program for providing the results of pharmaceutical supplier audits featuring technical analysis and evaluation of potential risks and safeguards;.

Its status is currently believed to be active. Its class is unavailable. “RX 360 JOINT AUDIT PROGRAM” is believed to be currently owned by “Rx-360 International Pharmaceutical Supply Chain Consortium”.


Owner:
RX-360 INTERNATIONAL PHARMACEUTICAL SUPPLY CHAIN CONSORTIUM
Owner Details
Description:
The mark consists of a capital R with the downward part of the angled leg of the R forming one half of a lower case X to the right and lower than the R next to the numbers 360 with the angled leg circling numbers 360 and a stylized global with an arching curved line reaching from the right of the R to the inside of the angled leg, with all the foregoing centered over the words JOINT AUDIT PROGRAM with initial capital letters and the letters forming the words JOINT AUDIT being thicker than the word PROGRAM.;RX THREE SIXTY JOINT AUDIT PROGRAM;Color is not claimed as a feature of the mark.;RX OR AUDIT PROGRAM;Organizing and conducting a product safety auditing program of pharmaceutical suppliers and pharmaceutical ingredient suppliers for technical analysis and evaluation of potential risks and safeguards; organizing and conducting an audit sharing program for providing the results of pharmaceutical supplier audits featuring technical analysis and evaluation of potential risks and safeguards;
Categories: